PTCT-JPM2025-1.13.25-vF

PTC Therapeutics –JP Morgan 20251Matthew B. Klein, MDCEOPTC Therapeutics 2025Pam and Kelsey living with PKUPTC Therapeutics – JP Morgan 2025PTC Therapeutics – JP Morgan 2025PTC Therapeutics – JP Morgan 2025PTC Therapeutics – JP Morgan 20253PTC Therapeutics – JP Morgan 2025This presentation contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this presentation, other than statements of historic fact, are forward-looking statements, including statements with respect to 2025 total revenue guidance and 2025 operating expenditure guidance and statements regarding: the future expectations, plans and prospects for PTC, including with respect to the expected timing of clinical trials and studies, availability of data, regulatory submissions and responses, commercialization and other matters with respect to its products and product candidates; PTC's strategy, future operations, future financial position, futu